WASHINGTON (AP) — Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about stroke, heart attack, dementia and other serious risks, the ...
Strategic Implications: Analytical findings reported today underscore ABP-450’s potential to become the first full label therapeutic biosimilar to BOTOX® in the U.S., positioning AEON to address a >$3 ...
Black box warnings – or as the FDA officially calls them, boxed warnings – are a tool for alerting pharmacists and clinicians that the medication may have serious risks. These health care ...
In this excerpt from the new book 'Speak Data,' the Wharton professor and best-selling author shares his thoughts on how we ...
FDA sign & Bldg 21 at Entrance PHOTO COURTESY OF COMMONS.WIKIMEDIA.ORG Washington (AP) — Hormone based drugs used to treat ...
The Inflation Reduction Act (IRA) of 2022 mandates price negotiations for certain drugs under Medicare, shortening the exclusivity period historically used to recoup research and development ...
Seven posters to be presented, including new X-TOLE OLE data supporting the ability to attain and regain extended periods of seizure freedom with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback